Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOSIMENDAN for Cardiogenic shock: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where LEVOSIMENDAN was used for Cardiogenic shock.

Most Reported Side Effects for LEVOSIMENDAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 64 35.0% 10 41
Cardiac failure 37 20.2% 10 30
Hypotension 37 20.2% 6 28
Off label use 28 15.3% 0 19
Respiratory failure 27 14.8% 4 16
Constipation 16 8.7% 0 16
Hypothyroidism 16 8.7% 0 16
Ejection fraction decreased 15 8.2% 4 14
Jugular vein distension 14 7.7% 0 14
Pulmonary hypertension 13 7.1% 0 11
Condition aggravated 12 6.6% 8 11
Cardiogenic shock 11 6.0% 1 10
Therapy non-responder 11 6.0% 4 6
Acidosis 10 5.5% 0 0
Pallor 10 5.5% 0 1

Other Indications for LEVOSIMENDAN

Product used for unknown indication (47) Cardiac failure (29) Cardiac failure congestive (18) Pulmonary hypertension (10) Cardiac failure acute (9) Haemodynamic instability (5) Hypotension (5)

Other Drugs Used for Cardiogenic shock

DOBUTAMINE (468) NOREPINEPHRINE (210) EPINEPHRINE (188) VASOPRESSIN (124) MILRINONE (87) DOPAMINE (48) NOREPINEPHRINE\NOREPINEPHRINE (36) PHENYLEPHRINE (36) AMIODARONE (33) METHYLPREDNISOLONE (25)

Related Pages

LEVOSIMENDAN Full Profile All Cardiogenic shock Drugs LEVOSIMENDAN Demographics LEVOSIMENDAN Timeline